Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Peona

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1996
Use of rifabutin in the treatment of pulmonary tuberculosisC Grassi, V Peona
The European Respiratory Journal. Supplement|September 1, 1995
New drugs for tuberculosisC Grassi, V Peona
Giornale Italiano Di Chemioterapia|July 1, 1982
[Current therapy for pulmonary tuberculosis]C Grassi, V Peona
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|September 1, 1994
TB treatment: yesterday, today and ... tomorrowC Grassi, V Peona
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|December 1, 1993
Mechanisms of lung injury in cystic fibrosisM Luisetti, F Meloni, V Peona
European Review for Medical and Pharmacological Sciences|June 18, 2002
Nebulized tobramycin in patients with chronic respiratory infections during clinical evolution of Wegener's granulomatosisC Terzano, A E Taurino, V Peona
Acta Medica Portuguesa|February 1, 1983
The use of cefotaxime in pneumologyC Grassi, M L Colombo, V Peona
Developments in Biological Standardization|January 1, 1986
[Comparison of Monotest and the intradermal reaction to tuberculin: search for a correlation]V Peona, E Roselli, L R Biasio
Giornale Italiano Di Chemioterapia|January 1, 1982
[Ambulatory anti-infective therapy. Multicentric studies with cefotaxime treatment of 12,181 patients]E Pozzi, M Luisetti, V Peona, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1983
In-vitro antibacterial activity of cefotetanG G Grassi, R Alesina, A Ferrara, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1996
Use of rifabutin in the treatment of pulmonary tuberculosisC Grassi, V Peona
The European Respiratory Journal. Supplement|September 1, 1995
New drugs for tuberculosisC Grassi, V Peona
Giornale Italiano Di Chemioterapia|July 1, 1982
[Current therapy for pulmonary tuberculosis]C Grassi, V Peona
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|September 1, 1994
TB treatment: yesterday, today and ... tomorrowC Grassi, V Peona
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|December 1, 1993
Mechanisms of lung injury in cystic fibrosisM Luisetti, F Meloni, V Peona
European Review for Medical and Pharmacological Sciences|June 18, 2002
Nebulized tobramycin in patients with chronic respiratory infections during clinical evolution of Wegener's granulomatosisC Terzano, A E Taurino, V Peona
Acta Medica Portuguesa|February 1, 1983
The use of cefotaxime in pneumologyC Grassi, M L Colombo, V Peona
Developments in Biological Standardization|January 1, 1986
[Comparison of Monotest and the intradermal reaction to tuberculin: search for a correlation]V Peona, E Roselli, L R Biasio
Giornale Italiano Di Chemioterapia|January 1, 1982
[Ambulatory anti-infective therapy. Multicentric studies with cefotaxime treatment of 12,181 patients]E Pozzi, M Luisetti, V Peona, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1983
In-vitro antibacterial activity of cefotetanG G Grassi, R Alesina, A Ferrara, et al.
Pageof 3